Table 2. Cumulative Hepatitis C Virus Screening Outcomes Among People Who Inject Drugs Seen at a Federally Qualified Health Center During an Intervention to Improve Screening for Hepatitis C Virus, Disaggregated by Demographic Variables, Midwestern US, 2019–2020.
| Characteristic | Not Screened | Screened | Total | χ2 P Value |
|---|---|---|---|---|
| Sex | ||||
| Female | 138 | 204 | 342 | .71 |
| Male | 156 | 244 | 400 | |
| Both sexes | 294 | 448 | 742 | |
| Age, y | ||||
| <30 | 65 | 97 | 162 | .25 |
| 30–39 | 105 | 153 | 258 | |
| 40–49 | 68 | 92 | 160 | |
| 50–59 | 36 | 82 | 118 | |
| ≥60 | 20 | 24 | 44 | |
| All ages | 294 | 448 | 742 | |
| Ethnicity | ||||
| Hispanic | 22 | 24 | 46 | .24 |
| Not Hispanic | 272 | 424 | 696 | |
| Both ethnicities | 294 | 448 | 742 | |